According to this study, over the next five years the Dry Powder Inhaler Device market will register a 5.1%% CAGR in terms of revenue, the global market size will reach $ 849.5 million by 2025, from $ 696.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dry Powder Inhaler Device business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhaler Device market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Dry Powder Inhaler Device, covering the supply chain analysis, impact assessment to the Dry Powder Inhaler Device market size growth rate in several scenarios, and the measures to be undertaken by Dry Powder Inhaler Device companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- Single Dose
- Multi-dose
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
- Asthma
- COPD
- Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- GlaxoSmithKline
- Novartis
- AstraZeneca
- Chiesi
- Cipla
- Boehringer Ingelheim
- Mannkind
- 3M
- Mylan
- Hovione
- Schering/Merck
- Vectura
- Teva
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
- To study and analyze the global Dry Powder Inhaler Device consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Dry Powder Inhaler Device market by identifying its various subsegments.
- Focuses on the key global Dry Powder Inhaler Device manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Dry Powder Inhaler Device with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Dry Powder Inhaler Device submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global Dry Powder Inhaler Device Market Growth 2020-2025
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dry Powder Inhaler Device Consumption 2015-2025
2.1.2 Dry Powder Inhaler Device Consumption CAGR by Region
2.2 Dry Powder Inhaler Device Segment by Type
2.2.1 Single Dose
2.2.2 Multi-dose
2.3 Dry Powder Inhaler Device Consumption by Type
2.3.1 Global Dry Powder Inhaler Device Consumption Market Share by Type (2015-2020)
2.3.2 Global Dry Powder Inhaler Device Revenue and Market Share by Type (2015-2020)
2.3.3 Global Dry Powder Inhaler Device Sale Price by Type (2015-2020)
2.4 Dry Powder Inhaler Device Segment by Application
2.4.1 Asthma
2.4.2 COPD
2.4.3 Other
2.5 Dry Powder Inhaler Device Consumption by Application
2.5.1 Global Dry Powder Inhaler Device Consumption Market Share by Type (2015-2020)
2.5.2 Global Dry Powder Inhaler Device Value and Market Share by Type (2015-2020)
2.5.3 Global Dry Powder Inhaler Device Sale Price by Type (2015-2020)
3 Global Dry Powder Inhaler Device by Company
3.1 Global Dry Powder Inhaler Device Sales Market Share by Company
3.1.1 Global Dry Powder Inhaler Device Sales by Company (2018-2020)
3.1.2 Global Dry Powder Inhaler Device Sales Market Share by Company (2018-2020)
3.2 Global Dry Powder Inhaler Device Revenue Market Share by Company
3.2.1 Global Dry Powder Inhaler Device Revenue by Company (2018-2020)
3.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Company (2018-2020)
3.3 Global Dry Powder Inhaler Device Sale Price by Company
3.4 Global Dry Powder Inhaler Device Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Dry Powder Inhaler Device Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Dry Powder Inhaler Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dry Powder Inhaler Device by Regions
4.1 Dry Powder Inhaler Device by Regions
4.2 Americas Dry Powder Inhaler Device Consumption Growth
4.3 APAC Dry Powder Inhaler Device Consumption Growth
4.4 Europe Dry Powder Inhaler Device Consumption Growth
4.5 Middle East & Africa Dry Powder Inhaler Device Consumption Growth
5 Americas
5.1 Americas Dry Powder Inhaler Device Consumption by Countries
5.1.1 Americas Dry Powder Inhaler Device Consumption by Countries (2015-2020)
5.1.2 Americas Dry Powder Inhaler Device Value by Countries (2015-2020)
5.2 Americas Dry Powder Inhaler Device Consumption by Type
5.3 Americas Dry Powder Inhaler Device Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Dry Powder Inhaler Device Consumption by Regions
6.1.1 APAC Dry Powder Inhaler Device Consumption by Regions (2015-2020)
6.1.2 APAC Dry Powder Inhaler Device Value by Regions (2015-2020)
6.2 APAC Dry Powder Inhaler Device Consumption by Type
6.3 APAC Dry Powder Inhaler Device Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Dry Powder Inhaler Device by Countries
7.1.1 Europe Dry Powder Inhaler Device Consumption by Countries (2015-2020)
7.1.2 Europe Dry Powder Inhaler Device Value by Countries (2015-2020)
7.2 Europe Dry Powder Inhaler Device Consumption by Type
7.3 Europe Dry Powder Inhaler Device Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Dry Powder Inhaler Device by Countries
8.1.1 Middle East & Africa Dry Powder Inhaler Device Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Dry Powder Inhaler Device Value by Countries (2015-2020)
8.2 Middle East & Africa Dry Powder Inhaler Device Consumption by Type
8.3 Middle East & Africa Dry Powder Inhaler Device Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dry Powder Inhaler Device Distributors
10.3 Dry Powder Inhaler Device Customer
11 Global Dry Powder Inhaler Device Market Forecast
11.1 Global Dry Powder Inhaler Device Consumption Forecast (2021-2025)
11.2 Global Dry Powder Inhaler Device Forecast by Regions
11.2.1 Global Dry Powder Inhaler Device Forecast by Regions (2021-2025)
11.2.2 Global Dry Powder Inhaler Device Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Dry Powder Inhaler Device Forecast by Type
11.8 Global Dry Powder Inhaler Device Forecast by Application
12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 Company Information
12.1.2 Dry Powder Inhaler Device Product Offered
12.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Novartis
12.2.1 Company Information
12.2.2 Dry Powder Inhaler Device Product Offered
12.2.3 Novartis Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Novartis Latest Developments
12.3 AstraZeneca
12.3.1 Company Information
12.3.2 Dry Powder Inhaler Device Product Offered
12.3.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 AstraZeneca Latest Developments
12.4 Chiesi
12.4.1 Company Information
12.4.2 Dry Powder Inhaler Device Product Offered
12.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Chiesi Latest Developments
12.5 Cipla
12.5.1 Company Information
12.5.2 Dry Powder Inhaler Device Product Offered
12.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Cipla Latest Developments
12.6 Boehringer Ingelheim
12.6.1 Company Information
12.6.2 Dry Powder Inhaler Device Product Offered
12.6.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Boehringer Ingelheim Latest Developments
12.7 Mannkind
12.7.1 Company Information
12.7.2 Dry Powder Inhaler Device Product Offered
12.7.3 Mannkind Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Mannkind Latest Developments
12.8 3M
12.8.1 Company Information
12.8.2 Dry Powder Inhaler Device Product Offered
12.8.3 3M Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 3M Latest Developments
12.9 Mylan
12.9.1 Company Information
12.9.2 Dry Powder Inhaler Device Product Offered
12.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Mylan Latest Developments
12.10 Hovione
12.10.1 Company Information
12.10.2 Dry Powder Inhaler Device Product Offered
12.10.3 Hovione Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hovione Latest Developments
12.11 Schering/Merck
12.11.1 Company Information
12.11.2 Dry Powder Inhaler Device Product Offered
12.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Schering/Merck Latest Developments
12.12 Vectura
12.12.1 Company Information
12.12.2 Dry Powder Inhaler Device Product Offered
12.12.3 Vectura Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Vectura Latest Developments
12.13 Teva
12.13.1 Company Information
12.13.2 Dry Powder Inhaler Device Product Offered
12.13.3 Teva Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Teva Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Dry Powder Inhaler Device Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Single Dose
Table 5. Major Players of Multi-dose
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Dry Powder Inhaler Device Consumption Market Share by Type (2015-2020)
Table 8. Global Dry Powder Inhaler Device Revenue by Type (2015-2020) ($ million)
Table 9. Global Dry Powder Inhaler Device Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Dry Powder Inhaler Device Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Dry Powder Inhaler Device Consumption Market Share by Application (2015-2020)
Table 13. Global Dry Powder Inhaler Device Value by Application (2015-2020)
Table 14. Global Dry Powder Inhaler Device Value Market Share by Application (2015-2020)
Table 15. Global Dry Powder Inhaler Device Sale Price by Application (2015-2020)
Table 16. Global Dry Powder Inhaler Device Sales by Company (2017-2019) (K Units)
Table 17. Global Dry Powder Inhaler Device Sales Market Share by Company (2017-2019)
Table 18. Global Dry Powder Inhaler Device Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Dry Powder Inhaler Device Revenue Market Share by Company (2017-2019)
Table 20. Global Dry Powder Inhaler Device Sale Price by Company (2017-2019)
Table 21. Global Dry Powder Inhaler Device Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Dry Powder Inhaler Device Products Offered
Table 23. Dry Powder Inhaler Device Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Dry Powder Inhaler Device Consumption by Regions 2015-2020 (K Units)
Table 25. Global Dry Powder Inhaler Device Consumption Market Share by Regions 2015-2020
Table 26. Global Dry Powder Inhaler Device Value by Regions 2015-2020 ($ Millions)
Table 27. Global Dry Powder Inhaler Device Value Market Share by Regions 2015-2020
Table 28. Americas Dry Powder Inhaler Device Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Dry Powder Inhaler Device Consumption Market Share by Countries (2015-2020)
Table 30. Americas Dry Powder Inhaler Device Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Dry Powder Inhaler Device Value Market Share by Countries (2015-2020)
Table 32. Americas Dry Powder Inhaler Device Consumption by Type (2015-2020) (K Units)
Table 33. Americas Dry Powder Inhaler Device Consumption Market Share by Type (2015-2020)
Table 34. Americas Dry Powder Inhaler Device Consumption by Application (2015-2020) (K Units)
Table 35. Americas Dry Powder Inhaler Device Consumption Market Share by Application (2015-2020)
Table 36. APAC Dry Powder Inhaler Device Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Dry Powder Inhaler Device Consumption Market Share by Countries (2015-2020)
Table 38. APAC Dry Powder Inhaler Device Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Dry Powder Inhaler Device Value Market Share by Regions (2015-2020)
Table 40. APAC Dry Powder Inhaler Device Consumption by Type (2015-2020) (K Units)
Table 41. APAC Dry Powder Inhaler Device Consumption Market Share by Type (2015-2020)
Table 42. APAC Dry Powder Inhaler Device Consumption by Application (2015-2020) (K Units)
Table 43. APAC Dry Powder Inhaler Device Consumption Market Share by Application (2015-2020)
Table 44. Europe Dry Powder Inhaler Device Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Dry Powder Inhaler Device Consumption Market Share by Countries (2015-2020)
Table 46. Europe Dry Powder Inhaler Device Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Dry Powder Inhaler Device Value Market Share by Countries (2015-2020)
Table 48. Europe Dry Powder Inhaler Device Consumption by Type (2015-2020) (K Units)
Table 49. Europe Dry Powder Inhaler Device Consumption Market Share by Type (2015-2020)
Table 50. Europe Dry Powder Inhaler Device Consumption by Application (2015-2020) (K Units)
Table 51. Europe Dry Powder Inhaler Device Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Dry Powder Inhaler Device Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Dry Powder Inhaler Device Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Dry Powder Inhaler Device Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Dry Powder Inhaler Device Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Dry Powder Inhaler Device Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Dry Powder Inhaler Device Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Dry Powder Inhaler Device Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Dry Powder Inhaler Device Consumption Market Share by Application (2015-2020)
Table 60. Dry Powder Inhaler Device Distributors List
Table 61. Dry Powder Inhaler Device Customer List
Table 62. Global Dry Powder Inhaler Device Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Dry Powder Inhaler Device Consumption Market Forecast by Regions
Table 64. Global Dry Powder Inhaler Device Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Dry Powder Inhaler Device Value Market Share Forecast by Regions
Table 66. Global Dry Powder Inhaler Device Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Dry Powder Inhaler Device Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Dry Powder Inhaler Device Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Dry Powder Inhaler Device Value Market Share Forecast by Type (2021-2025)
Table 70. Global Dry Powder Inhaler Device Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Dry Powder Inhaler Device Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Dry Powder Inhaler Device Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Dry Powder Inhaler Device Value Market Share Forecast by Application (2021-2025)
Table 74. GlaxoSmithKline Product Offered
Table 75. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. GlaxoSmithKline Main Business
Table 77. GlaxoSmithKline Latest Developments
Table 78. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Product Offered
Table 80. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Novartis Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 84. AstraZeneca Product Offered
Table 85. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. AstraZeneca Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 89. Chiesi Product Offered
Table 90. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Chiesi Main Business
Table 92. Chiesi Latest Developments
Table 93. Chiesi Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Cipla Product Offered
Table 95. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Cipla Main Business
Table 97. Cipla Latest Developments
Table 98. Cipla Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Boehringer Ingelheim Product Offered
Table 100. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Boehringer Ingelheim Main Business
Table 102. Boehringer Ingelheim Latest Developments
Table 103. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Mannkind Product Offered
Table 105. Mannkind Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 106. Mannkind Main Business
Table 107. Mannkind Latest Developments
Table 108. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. 3M Product Offered
Table 110. 3M Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. 3M Main Business
Table 112. 3M Latest Developments
Table 113. 3M Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Mylan Product Offered
Table 115. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Mylan Main Business
Table 117. Mylan Latest Developments
Table 118. Mylan Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Hovione Product Offered
Table 120. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. Hovione Main Business
Table 122. Hovione Latest Developments
Table 123. Hovione Basic Information, Company Total Revenue (in $ million), Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Schering/Merck Product Offered
Table 125. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. Schering/Merck Main Business
Table 127. Schering/Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Schering/Merck Latest Developments
Table 129. Vectura Product Offered
Table 130. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Vectura Main Business
Table 132. Vectura Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Vectura Latest Developments
Table 134. Teva Product Offered
Table 135. Teva Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Teva Main Business
Table 137. Teva Latest Developments
Table 138. Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Dry Powder Inhaler Device
Figure 2. Dry Powder Inhaler Device Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Dry Powder Inhaler Device Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Dry Powder Inhaler Device Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Single Dose
Figure 7. Product Picture of Multi-dose
Figure 8. Global Dry Powder Inhaler Device Consumption Market Share by Type (2015-2020)
Figure 9. Global Dry Powder Inhaler Device Value Market Share by Type (2015-2020)
Figure 10. Dry Powder Inhaler Device Consumed in Asthma
Figure 11. Global Dry Powder Inhaler Device Market: Asthma (2015-2020) (K Units)
Figure 12. Global Dry Powder Inhaler Device Market: Asthma (2015-2020) ($ Millions)
Figure 13. Dry Powder Inhaler Device Consumed in COPD
Figure 14. Global Dry Powder Inhaler Device Market: COPD (2015-2020) (K Units)
Figure 15. Global Dry Powder Inhaler Device Market: COPD (2015-2020) ($ Millions)
Figure 16. Dry Powder Inhaler Device Consumed in Other
Figure 17. Global Dry Powder Inhaler Device Market: Other (2015-2020) (K Units)
Figure 18. Global Dry Powder Inhaler Device Market: Other (2015-2020) ($ Millions)
Figure 19. Global Dry Powder Inhaler Device Consumption Market Share by Application (2015-2020)
Figure 20. Global Dry Powder Inhaler Device Value Market Share by Application (2015-2020)
Figure 21. Global Dry Powder Inhaler Device Sales Market Share by Company in 2017
Figure 22. Global Dry Powder Inhaler Device Sales Market Share by Company in 2019
Figure 23. Global Dry Powder Inhaler Device Revenue Market Share by Company in 2017
Figure 24. Global Dry Powder Inhaler Device Revenue Market Share by Company in 2019
Figure 25. Global Dry Powder Inhaler Device Sale Price by Company in 2019
Figure 26. Global Dry Powder Inhaler Device Consumption Market Share by Regions 2015-2020
Figure 27. Global Dry Powder Inhaler Device Value Market Share by Regions 2015-2020
Figure 28. Americas Dry Powder Inhaler Device Consumption 2015-2020 (K Units)
Figure 29. Americas Dry Powder Inhaler Device Value 2015-2020 ($ Millions)
Figure 30. APAC Dry Powder Inhaler Device Consumption 2015-2020 (K Units)
Figure 31. APAC Dry Powder Inhaler Device Value 2015-2020 ($ Millions)
Figure 32. Europe Dry Powder Inhaler Device Consumption 2015-2020 (K Units)
Figure 33. Europe Dry Powder Inhaler Device Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Dry Powder Inhaler Device Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Dry Powder Inhaler Device Value 2015-2020 ($ Millions)
Figure 36. Americas Dry Powder Inhaler Device Consumption Market Share by Countries in 2019
Figure 37. Americas Dry Powder Inhaler Device Value Market Share by Countries in 2019
Figure 38. Americas Dry Powder Inhaler Device Consumption Market Share by Type in 2019
Figure 39. Americas Dry Powder Inhaler Device Consumption Market Share by Application in 2019
Figure 40. United States Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 41. United States Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Dry Powder Inhaler Device Consumption Market Share by Countries in 2019
Figure 47. APAC Dry Powder Inhaler Device Value Market Share by Regions in 2019
Figure 48. APAC Dry Powder Inhaler Device Consumption Market Share by Type in 2019
Figure 49. APAC Dry Powder Inhaler Device Consumption Market Share by Application in 2019
Figure 50. China Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 51. China Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 58. India Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 59. India Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Dry Powder Inhaler Device Consumption Market Share by Countries in 2019
Figure 63. Europe Dry Powder Inhaler Device Value Market Share by Countries in 2019
Figure 64. Europe Dry Powder Inhaler Device Consumption Market Share by Type in 2019
Figure 65. Europe Dry Powder Inhaler Device Consumption Market Share by Application in 2019
Figure 66. Germany Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 68. France Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 69. France Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 70. UK Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 71. UK Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Dry Powder Inhaler Device Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Dry Powder Inhaler Device Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Dry Powder Inhaler Device Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Dry Powder Inhaler Device Consumption Market Share by Application in 2019
Figure 80. Egypt Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Dry Powder Inhaler Device Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Dry Powder Inhaler Device Value Growth 2015-2020 ($ Millions)
Figure 90. Global Dry Powder Inhaler Device Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Dry Powder Inhaler Device Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 93. Americas Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 94. APAC Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 95. APAC Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 96. Europe Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 97. Europe Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 100. United States Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 101. United States Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 102. Canada Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 103. Canada Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 104. Mexico Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 105. Mexico Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 106. Brazil Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 107. Brazil Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 108. China Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 109. China Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 110. Japan Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 111. Japan Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 112. Korea Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 113. Korea Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Dry Powder Inhaler Device Value 2021-2025 ($ Millions)
Figure 116. India Dry Powder Inhaler Device Consumption 2021-2025 (K Units)
Figure 11
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
